Wearable &
Device OEMs
Add differentiated, low-power health intelligence directly to connected products.
Device roadmap, sensor stack, compute envelope and target market.
Integration
· licensing
· co-development
SWEETDEEP™ · WEARABLE-AI METABOLIC INTELLIGENCE
Know your metabolic wellness earlier. Build habits that last.
SweetDeep turns everyday wearable signals into metabolic-wellness insights that support healthy habits — and healthy lifestyle choices may help reduce the risk of type 2 diabetes. Designed to meet people where life happens.
General-wellness notice. SweetDeep™ is in development. It does not provide a diagnosis, disease-risk score, glucose measurement or medical recommendation. Seek a qualified healthcare professional for medical questions.
WHY NOW
Three forces have converged.
The market no longer needs another wearable. It needs the disease-specific intelligence layer that turns existing devices into scalable screening infrastructure.
The opportunity is accelerating because hardware, AI and healthcare demand are finally aligned
Wearables
ECG + PPG + BIA + SpO2 consumer-scale sensors
Edge-AI
Private, low-cost on-device inference
Prevention
Healthcare shifting from reactive to proactive
$110B+ Wearable market today
$300B+ Wearable market by 2032
$413B Diabetes-risk TAM
THE NEUTIGERS APPROACH
Useful intelligence, closer to the sensor.
Multi-Sensor
Wearables
On-Device
AI Engine
Proprietary Edge-Optimized Deep Learning Algorithms
Digital
Biomarkers
Physiological Sensor Signals Transformed into Metabolic Insights
Risk
Prediction
AI predicts diabetes risk profile with robust accuracy, specificity, and sensitivity
Personalized
Insights
Intelligence that drive behavior change
Early Action
& Prevention
Early intervention reduces metabolic disease risk and healthcare costs
SweetDeep™
First Commercial Application for Diabetes Care
- Early Diabetes risk signals
- Clinically validated
- Integrated with Samsung watch
- 100% Non-invasive
- Risk prediction & prevention
- Seamless & engaging
- Low cost (single device)
General wellness only. These interface concepts do not diagnose, screen for, monitor or predict disease
EVIDENCE & DIFFERENTIATION
Built on more than an interface.
PARTNER PATHWAYS
Multiple ways to build together.
WHO WE PARTNER WITH USEFUL STARTING INPUTS TYPICAL ENGAGEMENT
Wearable &
Pharma &
Biotech
Generate continuous real-world evidence, enrich trials and explore digital companion pathways.
Therapeutic area, study objective, endpoints and participant profile.
Sponsored validation
· co-development
Providers &
Payers
Explore scalable risk identification, routing and preventive-care workflows.
Population, workflow, clinical objective and economic hypothesis.
Feasibility
· validation
· deployment
Research & Clinical
Institutions
Co-develop and validate digital biomarkers for high-unmet-need conditions.
Cohort, protocol, data access and scientific question.
Research collaboration
· sponsored study
Initial pathway
Consumer wellness
Metabolic Wellness insights and habit support.
Separate pathway
Investigational research
Disease-specific questions within defined studies.
Future pathway
Regulated functions
Only after applicable validation and authorization.
ABOUT NEUTIGERS
Wearable AI for everyday metabolic wellness.
NeuTigers is a Princeton-rooted health-AI company building the metabolic intelligence layer for consumer wearables. Our Edge-AI models run directly on smartwatches and phones, turning everyday sensor signals — ECG, PPG, bioimpedance, skin temperature, sleep and activity — into Metabolic Wellness insights that support healthy habits, with privacy preserved by on-device processing.
Behind the consumer experience sits an evidence program: a cardiometabolic knowledge base of roughly 2,000 study participants across the US, EU and MENA, peer-reviewed research, and compact AI models studied against biochemical reference standards. Explore the science and evidence, the StarDeep™ agentic platform, or partnership pathways for wearable OEMs, life-science companies, providers and researchers.
BUILD WITH NEUTIGERS